These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1160 related articles for article (PubMed ID: 33766124)

  • 1. Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor.
    Lee JG; Huang W; Lee H; van de Leemput J; Kane MA; Han Z
    Cell Biosci; 2021 Mar; 11(1):58. PubMed ID: 33766124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of SARS-CoV-2 proteins in Drosophila identifies Orf6-induced pathogenic effects with Selinexor as an effective treatment.
    Zhu JY; Lee JG; van de Leemput J; Lee H; Han Z
    Cell Biosci; 2021 Mar; 11(1):59. PubMed ID: 33766136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decoupling SARS-CoV-2 ORF6 localization and interferon antagonism.
    Wong HT; Cheung V; Salamango DJ
    J Cell Sci; 2022 Mar; 135(6):. PubMed ID: 35187564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanism of SARS-CoVs Orf6 Targeting the Rae1-Nup98 Complex to Compete With mRNA Nuclear Export.
    Li T; Wen Y; Guo H; Yang T; Yang H; Ji X
    Front Mol Biosci; 2021; 8():813248. PubMed ID: 35096974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage display technique identifies the interaction of severe acute respiratory syndrome coronavirus open reading frame 6 protein with nuclear pore complex interacting protein NPIPB3 in modulating Type I interferon antagonism.
    Huang SH; Lee TY; Lin YJ; Wan L; Lai CH; Lin CW
    J Microbiol Immunol Infect; 2017 Jun; 50(3):277-285. PubMed ID: 26320399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of SARS-CoV-2 protein ORF6 dislocates RAE1 and NUP98 from the nuclear pore complex.
    Kato K; Ikliptikawati DK; Kobayashi A; Kondo H; Lim K; Hazawa M; Wong RW
    Biochem Biophys Res Commun; 2021 Jan; 536():59-66. PubMed ID: 33360543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the SARS-CoV-2 ORF6 Mechanism of Action.
    Krachmarova E; Petkov P; Lilkova E; Ilieva N; Rangelov M; Todorova N; Malinova K; Hristova R; Nacheva G; Gospodinov A; Litov L
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.
    Kehrer T; Cupic A; Ye C; Yildiz S; Bouhaddou M; Crossland NA; Barrall EA; Cohen P; Tseng A; Çağatay T; Rathnasinghe R; Flores D; Jangra S; Alam F; Mena I; Aslam S; Saqi A; Rutkowska M; Ummadi MR; Pisanelli G; Richardson RB; Veit EC; Fabius JM; Soucheray M; Polacco BJ; Ak B; Marin A; Evans MJ; Swaney DL; Gonzalez-Reiche AS; Sordillo EM; van Bakel H; Simon V; Zuliani-Alvarez L; Fontoura BMA; Rosenberg BR; Krogan NJ; Martinez-Sobrido L; García-Sastre A; Miorin L
    Cell Host Microbe; 2023 Oct; 31(10):1668-1684.e12. PubMed ID: 37738983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.
    Kehrer T; Cupic A; Ye C; Yildiz S; Bouhhadou M; Crossland NA; Barrall E; Cohen P; Tseng A; Çağatay T; Rathnasinghe R; Flores D; Jangra S; Alam F; Mena N; Aslam S; Saqi A; Marin A; Rutkowska M; Ummadi MR; Pisanelli G; Richardson RB; Veit EC; Fabius JM; Soucheray M; Polacco BJ; Evans MJ; Swaney DL; Gonzalez-Reiche AS; Sordillo EM; van Bakel H; Simon V; Zuliani-Alvarez L; Fontoura BMA; Rosenberg BR; Krogan NJ; Martinez-Sobrido L; García-Sastre A; Miorin L
    bioRxiv; 2022 Nov; ():. PubMed ID: 36299428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-
    Krachmarova E; Petkov P; Lilkova E; Stoynova D; Malinova K; Hristova R; Gospodinov A; Ilieva N; Nacheva G; Litov L
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A putative diacidic motif in the SARS-CoV ORF6 protein influences its subcellular localization and suppression of expression of co-transfected expression constructs.
    Gunalan V; Mirazimi A; Tan YJ
    BMC Res Notes; 2011 Oct; 4():446. PubMed ID: 22026976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRL4B E3 ligase recruited by PRPF19 inhibits SARS-CoV-2 infection by targeting ORF6 for ubiquitin-dependent degradation.
    Zhang L; Hao P; Chen X; Lv S; Gao W; Li C; Li Z; Zhang W
    mBio; 2024 Feb; 15(2):e0307123. PubMed ID: 38265236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for Sarbecovirus ORF6 mediated blockage of nucleocytoplasmic transport.
    Gao X; Tian H; Zhu K; Li Q; Hao W; Wang L; Qin B; Deng H; Cui S
    Nat Commun; 2022 Aug; 13(1):4782. PubMed ID: 35970938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion.
    Gori Savellini G; Anichini G; Gandolfo C; Cusi MG
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of intracellular redox homeostasis by the SARS-CoV-2 ORF6 protein.
    De Angelis M; Anichini G; Palamara AT; Nencioni L; Gori Savellini G
    Virol J; 2023 Oct; 20(1):239. PubMed ID: 37853388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19.
    van de Leemput J; Han Z
    Mol Cell Biol; 2021 Aug; 41(9):e0018521. PubMed ID: 34124934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export.
    Hall R; Guedán A; Yap MW; Young GR; Harvey R; Stoye JP; Bishop KN
    PLoS Pathog; 2022 Aug; 18(8):e1010349. PubMed ID: 36007063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.
    Meyers JM; Ramanathan M; Shanderson RL; Donohue L; Ferguson I; Guo MG; Rao DS; Miao W; Reynolds D; Yang X; Zhao Y; Yang YY; Wang Y; Khavari PA
    bioRxiv; 2021 Feb; ():. PubMed ID: 33655243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
    Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
    J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo.
    Kashyap T; Murray J; Walker CJ; Chang H; Tamir S; Hou B; Shacham S; Kauffman MG; Tripp RA; Landesman Y
    Antiviral Res; 2021 Aug; 192():105115. PubMed ID: 34157321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.